David Jin - 26 Oct 2022 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role: Chief Financial Officer
Signature: /s/ David Jin
Issuer symbol: FBIO
Transactions as of: 26 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 28 Oct 2022, 17:02:20 UTC
Previous filing: 25 Aug 2022
Next filing: 02 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FBIO	COMMON STOCK, PAR VALUE $0.001	Award	$0	+1,350,000	+2823%	$0.000000	1,397,829	26 Oct 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of 1,350,000 restricted stock units which will vest in 48 equal monthly installments after the grant date, October 26, 2022. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.
F2	The total holdings include 1,350,000 shares underlying restricted stock units.

Content

Represents an award of 1,350,000 restricted stock units which will vest in 48 equal monthly installments after the grant date, October 26, 2022. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.

The total holdings include 1,350,000 shares underlying restricted stock units.